HIV News and Research

RSS

Success of covid antiviral pills hinges on access to speedy and accurate tests

Within a few weeks, perhaps before many Americans finish decorating for the holidays, the U.S. could have access to a new antiviral pill from Merck expected to alter the deadly trajectory of the covid-19 pandemic — with a second option from Pfizer to follow shortly after.

22 Nov 2021

Washington University joins international effort to support data science research and training in Africa

Washington University in St. Louis is joining a major international effort to advance data science, catalyze innovation and spur health discoveries across Africa.

21 Nov 2021

Novel technique solves structure of the HIV capsid alone and in complex with host factors

A new technique using electron tomography and subtomogram averaging at Diamond's electron Bio-Imaging Centre (eBIC), has solved the structure of the HIV capsid alone and in complex with host factors.

21 Nov 2021

Trial positions single-dose HPV vaccination as a high impact public health intervention

In the push to eliminate cervical cancer, researchers delivered hopeful news Nov. 17 at the 34th International Papillomavirus Conference in Toronto.

20 Nov 2021

First long-acting injectable HIV treatment appraised and approved by NICE

ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc, with Pfizer Inc. and Shionogi Limited as shareholders, is pleased to announce that eligible people living with Human Immunodeficiency Virus (HIV) in England and Wales will soon have routine access to Vocabria (cabotegravir long-acting injection) developed by ViiV Healthcare in combination with Rekambys (rilpivirine long-acting injection), developed by Janssen Sciences Ireland UC (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

19 Nov 2021

Viral biomolecular condensation

A review published in PLOS Pathogens deconstructs virus condensation and provides a biochemical background for LLPS.

19 Nov 2021

LSHTM expert comments on NICE approval of first long-acting injectable HIV treatment

NHS watch-dog, the National Institute for Health and Care Excellence (NICE), has published guidance recommending the use of the first long-acting injectable treatment for HIV-1.

18 Nov 2021

Antiretroviral drugs detected in drinking water

Years ago, there was a time that kids from a rural village in South Africa still wanted to swim in the rivers nearby. But when they got out of the water, those with sensitive skins would have the worst rash ever, says Prof Philiswa Nomngongo.

18 Nov 2021

Researchers identify compounds that tackle fungal infections in a new way

Current medications aren't particularly effective against fungi. The situation is becoming more challenging because these organisms are developing resistance to antimicrobial treatments, just as bacteria are.

17 Nov 2021

New art exhibition raises awareness of antimicrobial resistance

The UK Mission partnered with the Swedish Mission in Geneva to unveil a new art exhibition entitled 'The Silent Pandemic: No Time To Wait' to mark the start of World Antimicrobial Awareness Week today. Antimicrobial resistance (AMR) is one of the greatest public health threats facing the world.

17 Nov 2021

WHO joins global advocates to commemorate Day of Action for Cervical Cancer Elimination

Today WHO joins advocates around the world to commemorate a landmark Day of Action for Cervical Cancer Elimination and welcome groundbreaking new initiatives to end this devastating disease, which claims the lives of over 300 000 women each year.

17 Nov 2021

Study uncovers the herpes virus' strategy for infecting the nervous system

Herpes type 1 is sealed with a kiss for a lifetime. More than half of U.S. adults are carriers of HSV1 (herpes simplex virus type 1) which hibernates in the peripheral nervous system and can never be eradicated.

17 Nov 2021

Leading organizations announce funding for small-scale pilot dementia-related projects

Over the past five years, three leading organizations-;the Alzheimer's Association, Global Brain Health Institute (GBHI), and the UK-based Alzheimer's Society-;have united to address global challenges in dementia through a competitive funding program for emerging leaders in brain health and dementia.

17 Nov 2021

Two genetic risk variants in Black individuals may exacerbate sepsis and COVID-19 severity

Two genetic risk variants that are carried by nearly 40 percent of Black individuals may exacerbate the severity of both sepsis and COVID-19, a team of researchers from the University of Pennsylvania's Perelman School of Medicine have found.

16 Nov 2021

Your out-of-pocket health care costs need not be a mystery

If you've ever had a serious illness or cared for someone who has, you know how quickly the medical bills can pile up: from labs, radiology clinics, pharmacies, doctors, different departments within the same hospital — some of them in your insurance network, others not.

15 Nov 2021

Xanthohumol as a potent pan-inhibitor for various coronaviruses

Researchers from China reported the results of their study aimed at finding an effective Mpro inhibitor since Mpro is the best drug target to fight SARS-CoV-2 infection.

12 Nov 2021

INTEGRA’s VOYAGER helps HIV researchers get more results in significantly less time

INTEGRA’s VOYAGER adjustable tip spacing pipette is supporting crucial experimental work in longitudinal HIV studies.

From INTEGRA Biosciences 12 Nov 2021

Study tracks risk and protective behaviors related to transmission of HIV/AIDS in young adults

A number of behaviors in younger adults that increase risk for the transmission of HIV/AIDS have declined or changed between 2010 and 2020, according to the national Monitoring the Future study.

10 Nov 2021

ACTG announces launch of clinical trial evaluating a three-month TB treatment

The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, today announced the launch of A5362 (CLO-FAST), a clinical trial studying a three-month clofazimine- and high-dose rifapentine-containing treatment regimen for people with drug-susceptible tuberculosis (TB).

10 Nov 2021

Elusive white blood cells play a role in impaired T cell functions and counts in people with HIV

In a groundbreaking study of people living with HIV, University of Alberta researchers found that elusive white blood cells called neutrophils play a role in impaired T cell functions and counts, as well as the associated chronic inflammation that is common with the virus.

9 Nov 2021

HIV News and Research

Success of covid antiviral pills hinges on access to speedy and accurate tests

Washington University joins international effort to support data science research and training in Africa

Novel technique solves structure of the HIV capsid alone and in complex with host factors

Trial positions single-dose HPV vaccination as a high impact public health intervention

First long-acting injectable HIV treatment appraised and approved by NICE

Viral biomolecular condensation

LSHTM expert comments on NICE approval of first long-acting injectable HIV treatment

Antiretroviral drugs detected in drinking water

Researchers identify compounds that tackle fungal infections in a new way

New art exhibition raises awareness of antimicrobial resistance

WHO joins global advocates to commemorate Day of Action for Cervical Cancer Elimination

Study uncovers the herpes virus' strategy for infecting the nervous system

Leading organizations announce funding for small-scale pilot dementia-related projects

Two genetic risk variants in Black individuals may exacerbate sepsis and COVID-19 severity

Your out-of-pocket health care costs need not be a mystery

Xanthohumol as a potent pan-inhibitor for various coronaviruses

INTEGRA’s VOYAGER helps HIV researchers get more results in significantly less time

Study tracks risk and protective behaviors related to transmission of HIV/AIDS in young adults

ACTG announces launch of clinical trial evaluating a three-month TB treatment

Elusive white blood cells play a role in impaired T cell functions and counts in people with HIV

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News